These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 32227453)

  • 1. Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation.
    Wang Q; Lu P; Wang T; Zheng Q; Li Y; Leng SX; Meng X; Wang B; Xie J; Zhang H
    Cancer Med; 2020 Jun; 9(11):3816-3828. PubMed ID: 32227453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
    Miao J; Kyoyama H; Liu L; Chan G; Wang Y; Urisman A; Yang YL; Liu S; Xu Z; Bin H; Li H; Jablons DM; You L
    J Cell Mol Med; 2020 Jan; 24(1):1087-1098. PubMed ID: 31755214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1.
    Jiang Y; Fu L; Liu B; Li F
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):130037. PubMed ID: 38331059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin Suppresses Cell Tumorigenesis in Gastric Cancer Associated with the Inhibition of c-Myc and Yap-1.
    Zhang F; Chu M; Liu J; Zhao Q; Zhu Y; Wu X
    Comb Chem High Throughput Screen; 2024; 27(13):1919-1929. PubMed ID: 37957853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer.
    Ju J; Zhang H; Lin M; Yan Z; An L; Cao Z; Geng D; Yue J; Tang Y; Tian L; Chen F; Han Y; Wang W; Zhao S; Jiao S; Zhou Z
    J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38512451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.
    Caron JM; Han X; Contois L; Vary CPH; Brooks PC
    Am J Pathol; 2018 Oct; 188(10):2356-2368. PubMed ID: 30118657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer.
    Wang ZW; Yu QY; Xu MJ; Zhou CY; Li JP; Liao XH
    Aging (Albany NY); 2024 Jan; 16(1):285-298. PubMed ID: 38180746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity.
    Matafora V; Farris F; Restuccia U; Tamburri S; Martano G; Bernardelli C; Sofia A; Pisati F; Casagrande F; Lazzari L; Marsoni S; Bonoldi E; Bachi A
    EMBO Rep; 2020 Sep; 21(9):e50446. PubMed ID: 32749065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.
    Chen A; Santana AL; Doudican N; Roudiani N; Laursen K; Therrien JP; Lee J; Felsen D; Carucci JA
    PLoS One; 2020; 15(11):e0241551. PubMed ID: 33227008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
    Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGEA3 promotes proliferation and suppresses apoptosis in cervical cancer cells by inhibiting the KAP1/p53 signaling pathway.
    Gao X; Li Q; Chen G; He H; Ma Y
    Am J Transl Res; 2020; 12(7):3596-3612. PubMed ID: 32774721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury.
    Han W; Li Y; Cheng J; Zhang J; Chen D; Fang M; Xiang G; Wu Y; Zhang H; Xu K; Wang H; Xie L; Xiao J
    J Cell Mol Med; 2020 Aug; 24(15):8687-8702. PubMed ID: 32573108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
    Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
    IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.
    Huang XY; Zhang PF; Wei CY; Peng R; Lu JC; Gao C; Cai JB; Yang X; Fan J; Ke AW; Zhou J; Shi GM
    Mol Cancer; 2020 May; 19(1):92. PubMed ID: 32430013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hippo pathway in endometrial cancer: a potential therapeutic target?
    Shen X; Li Q; Sun Y; Chen L; Xue F; Tian W; Wang Y
    Front Oncol; 2023; 13():1273345. PubMed ID: 37927473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses.
    Ansari S; Nikpour P
    Adv Biomed Res; 2023; 12():52. PubMed ID: 37057240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
    Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment.
    Zhan ZT; Liu L; Cheng MZ; Gao Y; Zhou WJ
    J Immunol Res; 2022; 2022():2651790. PubMed ID: 36033393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.
    Bhat AS; Singh NA; Rymbai E; Birendra S; Jayaram S; Selvaraj D
    Reprod Sci; 2023 May; 30(5):1383-1398. PubMed ID: 35969363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents.
    Zhu S; Bai Q; Li L; Xu T
    Comput Struct Biotechnol J; 2022; 20():2839-2847. PubMed ID: 35765655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.